Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Interview with Klaus Rose

Articles in this issue

Related Content

Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial

The Data Behind Reducing Trial Burden Without Sacrificing Quality

ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch

Why Four Regulatory Scenarios Could De-Risk Selective Safety Data Collection

NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market

Trending on Applied Clinical Trials Online

NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market

ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch

ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value

Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors

ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion